{"id": "article-19453_0", "title": "Cholecystokinin Test -- Introduction", "content": "Cholecystokinin (CCK), formerly referred to as pancreozymins,\u00a0is another hormone-like secretin used in the pancreas's stimulation. Secretin\u00a0mainly stimulates the\u00a0secretion\u00a0of pancreatic juice,\u00a0which contains\u00a0pancreatic enzymes\u00a0and acts on the gallbladder,\u00a0which can assess gallbladder function. [1] CCK increases pancreatic enzyme output and causes gallbladder contraction. [1] Therefore, the CCK test can help\u00a0to diagnose biliary tract diseases.", "contents": "Cholecystokinin Test -- Introduction. Cholecystokinin (CCK), formerly referred to as pancreozymins,\u00a0is another hormone-like secretin used in the pancreas's stimulation. Secretin\u00a0mainly stimulates the\u00a0secretion\u00a0of pancreatic juice,\u00a0which contains\u00a0pancreatic enzymes\u00a0and acts on the gallbladder,\u00a0which can assess gallbladder function. [1] CCK increases pancreatic enzyme output and causes gallbladder contraction. [1] Therefore, the CCK test can help\u00a0to diagnose biliary tract diseases."}
{"id": "article-19453_1", "title": "Cholecystokinin Test -- Introduction", "content": "Cholecystokinin-cholescintigraphy (CCK-HIDA) is the gold standard test for evaluating patients for obstructive cholecystitis or biliary dyskinesia. The finding of an abnormal gallbladder ejection fraction (GBEF) could signal the presence of\u00a0an array of disease entities, including biliary dyskinesia, chronic or acute cholecystitis, bile sludging, etc. The HIDA may also demonstrate a filling defect,\u00a0which represents a likely stone lodged in the cystic duct. Cholecystectomy\u00a0is the recommended approach for those with abnormal GBEF and abdominal pain. [2]", "contents": "Cholecystokinin Test -- Introduction. Cholecystokinin-cholescintigraphy (CCK-HIDA) is the gold standard test for evaluating patients for obstructive cholecystitis or biliary dyskinesia. The finding of an abnormal gallbladder ejection fraction (GBEF) could signal the presence of\u00a0an array of disease entities, including biliary dyskinesia, chronic or acute cholecystitis, bile sludging, etc. The HIDA may also demonstrate a filling defect,\u00a0which represents a likely stone lodged in the cystic duct. Cholecystectomy\u00a0is the recommended approach for those with abnormal GBEF and abdominal pain. [2]"}
{"id": "article-19453_2", "title": "Cholecystokinin Test -- Introduction", "content": "GBEF is calculated as the flow of radioactive tracer that is ejected from the gallbladder. A\u00a0GBEF of <35% is considered abnormal. Patients considered for CCK-HIDA are those presenting with functional biliary pain based on the Rome III criteria. Those who present with atypical pain\u00a0may not need as HIDA as the presentation may be from other pathology. [2]", "contents": "Cholecystokinin Test -- Introduction. GBEF is calculated as the flow of radioactive tracer that is ejected from the gallbladder. A\u00a0GBEF of <35% is considered abnormal. Patients considered for CCK-HIDA are those presenting with functional biliary pain based on the Rome III criteria. Those who present with atypical pain\u00a0may not need as HIDA as the presentation may be from other pathology. [2]"}
{"id": "article-19453_3", "title": "Cholecystokinin Test -- Procedures", "content": "Preparation : Patients are required to be nil per os (NPO) for up to 4 hours before the CCK test; this is to avoid endogenous secretion of CCK, which can cause gallbladder contraction and, in turn, inhibit the absorption of the radiotracer, which may lead to false-positive test results. During the period of prolonged fasting, bile in the gall bladder becomes too vicious and turns into sludge, which prevents the radiotracer from entering the gallbladder. [3] CCK\u00a0is used\u00a0to\u00a0dislodge this sludge before the CCK-HIDA scan to avoid false positives. 2. The physician should make a note of the other medications taken by the patient.", "contents": "Cholecystokinin Test -- Procedures. Preparation : Patients are required to be nil per os (NPO) for up to 4 hours before the CCK test; this is to avoid endogenous secretion of CCK, which can cause gallbladder contraction and, in turn, inhibit the absorption of the radiotracer, which may lead to false-positive test results. During the period of prolonged fasting, bile in the gall bladder becomes too vicious and turns into sludge, which prevents the radiotracer from entering the gallbladder. [3] CCK\u00a0is used\u00a0to\u00a0dislodge this sludge before the CCK-HIDA scan to avoid false positives. 2. The physician should make a note of the other medications taken by the patient."}
{"id": "article-19453_4", "title": "Cholecystokinin Test -- Procedures", "content": "3. Intravenous access: Before gaining intravenous access, the patient receives instruction regarding the procedure of the test. After\u00a0this counseling session,\u00a0the CCK will be injected through the vein, and the imaging done over the patient's abdomen. During that time, the patient should remain still. Sincalide is the synthetically\u00a0prepared C-terminal octapeptide of cholecystokinin commonly used in\u00a0nuclear medicine hepatobiliary studies. Its purpose is to reduce the size of the gallbladder by emptying it for better visualization. [4] Crick and his colleagues designed a method used to prepare for CCK testing. This method included\u00a0assaying\u00a0CCK from pig intestine after infusing it with 1.7 units per kilogram of secretin for each dose. [1] At present, 40 ng/kg/hr of CCK infusion for five minutes after\u00a0using a secretin test dose (intravenous bolus of 0.2 mcg/kg). [5] Pain medications like morphine may also be used during the procedure.", "contents": "Cholecystokinin Test -- Procedures. 3. Intravenous access: Before gaining intravenous access, the patient receives instruction regarding the procedure of the test. After\u00a0this counseling session,\u00a0the CCK will be injected through the vein, and the imaging done over the patient's abdomen. During that time, the patient should remain still. Sincalide is the synthetically\u00a0prepared C-terminal octapeptide of cholecystokinin commonly used in\u00a0nuclear medicine hepatobiliary studies. Its purpose is to reduce the size of the gallbladder by emptying it for better visualization. [4] Crick and his colleagues designed a method used to prepare for CCK testing. This method included\u00a0assaying\u00a0CCK from pig intestine after infusing it with 1.7 units per kilogram of secretin for each dose. [1] At present, 40 ng/kg/hr of CCK infusion for five minutes after\u00a0using a secretin test dose (intravenous bolus of 0.2 mcg/kg). [5] Pain medications like morphine may also be used during the procedure."}
{"id": "article-19453_5", "title": "Cholecystokinin Test -- Indications", "content": "Abdominal pain is a frequent complaint and the reason many people present to emergency departments or clinics.\u00a0Right upper quadrant pain is commonly\u00a0associated with biliary diseases. Qualitative cholescintigraphy can evaluate gall bladder emptying.", "contents": "Cholecystokinin Test -- Indications. Abdominal pain is a frequent complaint and the reason many people present to emergency departments or clinics.\u00a0Right upper quadrant pain is commonly\u00a0associated with biliary diseases. Qualitative cholescintigraphy can evaluate gall bladder emptying."}
{"id": "article-19453_6", "title": "Cholecystokinin Test -- Indications", "content": "Clinicians often employ CCK cholescintigraphy/HIDA when biliary pain presents with a RUQ ultrasound showing obvious gallstones or in a normal-appearing ultrasound in the setting of classic physical exam findings associated with biliary disease. [6]", "contents": "Cholecystokinin Test -- Indications. Clinicians often employ CCK cholescintigraphy/HIDA when biliary pain presents with a RUQ ultrasound showing obvious gallstones or in a normal-appearing ultrasound in the setting of classic physical exam findings associated with biliary disease. [6]"}
{"id": "article-19453_7", "title": "Cholecystokinin Test -- Indications", "content": "Chronic cholecystitis is clinically diagnosed by poor gallbladder contractility due to prolonged inflammation. HIDA helps diagnose not only the\u00a0delayed emptying but also the impaired squeeze of the GB musculature. [2] When there is high clinical suspicion of a calculus obstruction, the HIDA scan without CCK\u00a0helps demonstrate GB filling but not squeeze.", "contents": "Cholecystokinin Test -- Indications. Chronic cholecystitis is clinically diagnosed by poor gallbladder contractility due to prolonged inflammation. HIDA helps diagnose not only the\u00a0delayed emptying but also the impaired squeeze of the GB musculature. [2] When there is high clinical suspicion of a calculus obstruction, the HIDA scan without CCK\u00a0helps demonstrate GB filling but not squeeze."}
{"id": "article-19453_8", "title": "Cholecystokinin Test -- Potential Diagnosis", "content": "CCK-HIDA scan is used to diagnose or rule out the following potential diagnoses: Gallbladder dyskinesia Biliary dyskinesia Acute acalculous cholecystitis Acute calculous cholecystitis Chronic cholecystitis Functional biliary disease Prolonged fasting [3]", "contents": "Cholecystokinin Test -- Potential Diagnosis. CCK-HIDA scan is used to diagnose or rule out the following potential diagnoses: Gallbladder dyskinesia Biliary dyskinesia Acute acalculous cholecystitis Acute calculous cholecystitis Chronic cholecystitis Functional biliary disease Prolonged fasting [3]"}
{"id": "article-19453_9", "title": "Cholecystokinin Test -- Normal and Critical Findings", "content": "A GBEF of < 35% after a 3-minute infusion is considered abnormal.\u00a0However, the symptoms of a few patients did not resolve after cholecystectomy. Previous studies show that those with such false positive GBEF received unnecessary cholecystectomy. [7] All these findings confirm that the symptoms can be secondary to a non-biliary cause and that this procedure could yield definite false positives. [7]", "contents": "Cholecystokinin Test -- Normal and Critical Findings. A GBEF of < 35% after a 3-minute infusion is considered abnormal.\u00a0However, the symptoms of a few patients did not resolve after cholecystectomy. Previous studies show that those with such false positive GBEF received unnecessary cholecystectomy. [7] All these findings confirm that the symptoms can be secondary to a non-biliary cause and that this procedure could yield definite false positives. [7]"}
{"id": "article-19453_10", "title": "Cholecystokinin Test -- Normal and Critical Findings", "content": "Various researchers, over the years, studied different doses and infusion times for the CCK test.\u00a0The challenge of using this important test is to find the correct combination of dose and time, which provides the least variability.\u00a0 Following more\u00a0robust studies, the Hepatobiliary Practice Guideline of the Society of Nuclear Medicine recommends that a 60-minute infusion of CCK\u00a0 at the rate of 0.02 mcg/kg be considered the standard method where GBEF of >38%\u00a0is normal. [7]", "contents": "Cholecystokinin Test -- Normal and Critical Findings. Various researchers, over the years, studied different doses and infusion times for the CCK test.\u00a0The challenge of using this important test is to find the correct combination of dose and time, which provides the least variability.\u00a0 Following more\u00a0robust studies, the Hepatobiliary Practice Guideline of the Society of Nuclear Medicine recommends that a 60-minute infusion of CCK\u00a0 at the rate of 0.02 mcg/kg be considered the standard method where GBEF of >38%\u00a0is normal. [7]"}
{"id": "article-19453_11", "title": "Cholecystokinin Test -- Normal and Critical Findings", "content": "Chronic cholecystitis is the diagnosis\u00a0when the GBEF is 6%, with the infusion of 0.01 mcg/kg of CCK over 3 minutes. There is significant variability in the GBEF when using this technique since different doses, and infusion rates can yield false-positive results. An abnormal response to CCK stimulation by the sphincter of Oddi\u00a0is\u00a0also observable in patients with irritable bowel syndrome.", "contents": "Cholecystokinin Test -- Normal and Critical Findings. Chronic cholecystitis is the diagnosis\u00a0when the GBEF is 6%, with the infusion of 0.01 mcg/kg of CCK over 3 minutes. There is significant variability in the GBEF when using this technique since different doses, and infusion rates can yield false-positive results. An abnormal response to CCK stimulation by the sphincter of Oddi\u00a0is\u00a0also observable in patients with irritable bowel syndrome."}
{"id": "article-19453_12", "title": "Cholecystokinin Test -- Interfering Factors", "content": "Food intake is the major factor that interferes with this test.\u00a0False positives arise based on the contracted state of the gallbladder in the presence of food. [3] Of note, patients who have been kept NPO for an extended period may have thicker bile, often referred to as sludge, which may affect the test results leading\u00a0to\u00a0false positives.", "contents": "Cholecystokinin Test -- Interfering Factors. Food intake is the major factor that interferes with this test.\u00a0False positives arise based on the contracted state of the gallbladder in the presence of food. [3] Of note, patients who have been kept NPO for an extended period may have thicker bile, often referred to as sludge, which may affect the test results leading\u00a0to\u00a0false positives."}
{"id": "article-19453_13", "title": "Cholecystokinin Test -- Complications", "content": "The test is usually safe; however, the patients undergoing the test should receive information regarding the necessary precautions. Pain - If using a HIDA scan with CCK, patients should be warned that the test will likely bring on very similar pain to what they felt previously, especially in the setting of calculus. The test may be very painful. Allergy Radiation exposure Bruising/thrombophlebitis at the site of the IV infusion", "contents": "Cholecystokinin Test -- Complications. The test is usually safe; however, the patients undergoing the test should receive information regarding the necessary precautions. Pain - If using a HIDA scan with CCK, patients should be warned that the test will likely bring on very similar pain to what they felt previously, especially in the setting of calculus. The test may be very painful. Allergy Radiation exposure Bruising/thrombophlebitis at the site of the IV infusion"}
{"id": "article-19453_14", "title": "Cholecystokinin Test -- Patient Safety and Education", "content": "Patients\u00a0with\u00a0abdominal pain and, generally, an ultrasound that shows gallstones often receive a referral to undergo a CCK-HIDA scan. The patients must understand that this test will determine the functionality of their gall bladder. An abnormal GBEF of <35%\u00a0confirms that a diagnosis of biliary dyskinesia, or with a filling defect that an obstructed cystic duct is present and cholecystectomy may relieve their symptoms. It is a good prediction for the successful resolution of symptoms following cholecystectomy. This procedure is tolerated\u00a0well by the patients. [8] As the radioactive tracer may take some days to exit from the bloodstream via urine or stool, the patients should increase the intake of water for a short period post-procedure.", "contents": "Cholecystokinin Test -- Patient Safety and Education. Patients\u00a0with\u00a0abdominal pain and, generally, an ultrasound that shows gallstones often receive a referral to undergo a CCK-HIDA scan. The patients must understand that this test will determine the functionality of their gall bladder. An abnormal GBEF of <35%\u00a0confirms that a diagnosis of biliary dyskinesia, or with a filling defect that an obstructed cystic duct is present and cholecystectomy may relieve their symptoms. It is a good prediction for the successful resolution of symptoms following cholecystectomy. This procedure is tolerated\u00a0well by the patients. [8] As the radioactive tracer may take some days to exit from the bloodstream via urine or stool, the patients should increase the intake of water for a short period post-procedure."}
{"id": "article-19453_15", "title": "Cholecystokinin Test -- Clinical Significance", "content": "Previously, clinicians used fatty meals to ascertain the status of gallbladder function, however, it had its limitations and did not give the same evidence as a 60-minute infusion of CCK gives. [7] CCK- infusion method is substantiated and is\u00a0better tolerated by patients, especially those with severe abdominal pain.", "contents": "Cholecystokinin Test -- Clinical Significance. Previously, clinicians used fatty meals to ascertain the status of gallbladder function, however, it had its limitations and did not give the same evidence as a 60-minute infusion of CCK gives. [7] CCK- infusion method is substantiated and is\u00a0better tolerated by patients, especially those with severe abdominal pain."}
{"id": "article-19453_16", "title": "Cholecystokinin Test -- Clinical Significance", "content": "The CCK-cholescintigraphy test is useful in predicting the efficacy of cholecystectomy, and it is the gold standard for assessing gallbladder emptying and function. [6] Effectively, the CCK-HIDA/scintigraphy can rule out functional obstruction of the cystic duct; this may be from biliary dyskinesia (failure of gallbladder contraction) or acalculous cholecystitis (sludging of bile). Patients with abnormal GBEF on a CCK test, tend to have a complete resolution of their symptoms following cholecystectomy. [8]", "contents": "Cholecystokinin Test -- Clinical Significance. The CCK-cholescintigraphy test is useful in predicting the efficacy of cholecystectomy, and it is the gold standard for assessing gallbladder emptying and function. [6] Effectively, the CCK-HIDA/scintigraphy can rule out functional obstruction of the cystic duct; this may be from biliary dyskinesia (failure of gallbladder contraction) or acalculous cholecystitis (sludging of bile). Patients with abnormal GBEF on a CCK test, tend to have a complete resolution of their symptoms following cholecystectomy. [8]"}
{"id": "article-19453_17", "title": "Cholecystokinin Test -- Clinical Significance", "content": "Despite all the guidelines and research, knowing the actual value of a GBEF in a diseased patient is not clear. All values used to define\u00a0abnormal GBEF are based on healthy individuals. [2] Therefore, it is the responsibility of clinicians to consider the larger picture while diagnosing biliary or gallbladder dyskinesia.", "contents": "Cholecystokinin Test -- Clinical Significance. Despite all the guidelines and research, knowing the actual value of a GBEF in a diseased patient is not clear. All values used to define\u00a0abnormal GBEF are based on healthy individuals. [2] Therefore, it is the responsibility of clinicians to consider the larger picture while diagnosing biliary or gallbladder dyskinesia."}
{"id": "article-19453_18", "title": "Cholecystokinin Test -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Cholecystokinin Test -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}